|
|
Article: FDA Approves Frova (Frovatriptan Succinate).(Brief Article)
- Article from:
- Pain & Central Nervous System Week
- Article date:
- December 10, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 DEC 10 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has approved Frova (frovatriptan succinate) 2.5 mg tablets, for the acute treatment of migraine attacks with or without aura in adults, according to Elan Corp., PLC (ELN).
"The FDA's approval of Frova is a key milestone in advancing our pipeline of important products for patients with neurological disorders," said Donal J. Geaney, chairman and chief executive officer of Elan. We are excited to bring to patients who suffer from migraine headaches Frova, a new medicine for migraine. We are in discussions with potential copromotion partners and expect to conclude our launch plan this ...